These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

997 related articles for article (PubMed ID: 32521474)

  • 21. Effects of the Fasting-Postprandial State on Arterial Spin Labeling MRI-Based Cerebral Perfusion Quantification in Alzheimer's Disease.
    Li R; Zhuo Z; Hong Y; Yao Z; Li Z; Wang Y; Jiang J; Wang L; Jia Z; Sun M; Zhang Y; Li W; Ren Q; Zhang Y; Duan Y; Liu Y; Wei H; Zhang Y; Chappell M; Shi H; Liu Y; Xu J
    J Magn Reson Imaging; 2024 Nov; 60(5):2173-2183. PubMed ID: 38544434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined effects of type 2 diabetes and hypertension associated with cortical thinning and impaired cerebrovascular reactivity relative to hypertension alone in older adults.
    Tchistiakova E; Anderson ND; Greenwood CE; MacIntosh BJ
    Neuroimage Clin; 2014; 5():36-41. PubMed ID: 24967157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.
    Thomas KR; Osuna JR; Weigand AJ; Edmonds EC; Clark AL; Holmqvist S; Cota IH; Wierenga CE; Bondi MW; Bangen KJ;
    J Cereb Blood Flow Metab; 2021 May; 41(5):1001-1012. PubMed ID: 32615887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
    Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
    J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and
    Riederer I; Bohn KP; Preibisch C; Wiedemann E; Zimmer C; Alexopoulos P; Förster S
    Radiology; 2018 Jul; 288(1):198-206. PubMed ID: 29762090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of cerebral blood flow in Alzheimer disease and vascular dementia.
    Yoshikawa T; Murase K; Oku N; Imaizumi M; Takasawa M; Rishu P; Kimura Y; Ikejiri Y; Kitagawa K; Hori M; Hatazawa J
    AJNR Am J Neuroradiol; 2003 Aug; 24(7):1341-7. PubMed ID: 12917125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant vascular architecture in the hippocampus correlates with tau burden in mild cognitive impairment and Alzheimer's disease.
    Lee H; Fu JF; Gaudet K; Bryant AG; Price JC; Bennett RE; Johnson KA; Hyman BT; Hedden T; Salat DH; Yen YF; Huang SY
    J Cereb Blood Flow Metab; 2024 May; 44(5):787-800. PubMed ID: 38000018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD.
    Bryant AG; Manhard MK; Salat DH; Rosen BR; Hyman BT; Johnson KA; Huang S; Bennett RE; Yen YF
    Curr Alzheimer Res; 2021; 18(9):711-720. PubMed ID: 34825871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Default Mode Network Connectivity and Related White Matter Disruption in Type 2 Diabetes Mellitus Patients Concurrent with Amnestic Mild Cognitive Impairment.
    Qi D; Wang A; Chen Y; Chen K; Zhang S; Zhang J; Li X; Ai L; Zhang Z
    Curr Alzheimer Res; 2017; 14(11):1238-1246. PubMed ID: 28413981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can we predict amyloid deposition by objective cognition and regional cerebral blood flow in patients with subjective cognitive decline?
    Funaki K; Nakajima S; Noda Y; Wake T; Ito D; Yamagata B; Yoshizaki T; Kameyama M; Nakahara T; Murakami K; Jinzaki M; Mimura M; Tabuchi H
    Psychogeriatrics; 2019 Jul; 19(4):325-332. PubMed ID: 30688000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain structure, amyloid, and behavioral features for predicting clinical progression in subjective cognitive decline.
    Liu S; Luo X; Chong JSX; Jiaerken Y; Youn SH; Zhang M; Zhou JH;
    Hum Brain Mapp; 2024 Jul; 45(10):e26765. PubMed ID: 38958401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcranial and extracranial ultrasound assessment of cerebral hemodynamics in vascular and Alzheimer's dementia.
    Doepp F; Valdueza JM; Schreiber SJ
    Neurol Res; 2006 Sep; 28(6):645-9. PubMed ID: 16945217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults.
    Jefferson AL; Cambronero FE; Liu D; Moore EE; Neal JE; Terry JG; Nair S; Pechman KR; Rane S; Davis LT; Gifford KA; Hohman TJ; Bell SP; Wang TJ; Beckman JA; Carr JJ
    Circulation; 2018 Oct; 138(18):1951-1962. PubMed ID: 30018169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease.
    Leeuwis AE; Benedictus MR; Kuijer JPA; Binnewijzend MAA; Hooghiemstra AM; Verfaillie SCJ; Koene T; Scheltens P; Barkhof F; Prins ND; van der Flier WM
    Alzheimers Dement; 2017 May; 13(5):531-540. PubMed ID: 27693109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood Pressure is Associated With Cerebral Blood Flow Alterations in Patients With T2DM as Revealed by Perfusion Functional MRI.
    Xia W; Rao H; Spaeth AM; Huang R; Tian S; Cai R; Sun J; Wang S
    Medicine (Baltimore); 2015 Dec; 94(48):e2231. PubMed ID: 26632913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease.
    Jann K; Shao X; Ma SJ; Cen SY; D'Orazio L; Barisano G; Yan L; Casey M; Lamas J; Staffaroni AM; Kramer JH; Ringman JM; Wang DJJ
    Front Neurosci; 2021; 15():627627. PubMed ID: 33584191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different post label delay cerebral blood flow measurements in patients with Alzheimer's disease using 3D arterial spin labeling.
    Liu Y; Zeng X; Wang Z; Zhang N; Fan D; Yuan H
    Magn Reson Imaging; 2015 Nov; 33(9):1019-1025. PubMed ID: 26113261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease.
    Swinford CG; Risacher SL; Vosmeier A; Deardorff R; Chumin EJ; Dzemidzic M; Wu YC; Gao S; McDonald BC; Yoder KK; Unverzagt FW; Wang S; Farlow MR; Brosch JR; Clark DG; Apostolova LG; Sims J; Wang DJ; Saykin AJ
    Neurobiol Aging; 2023 Oct; 130():103-113. PubMed ID: 37499587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.